Your browser doesn't support javascript.
loading
Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.
Pitts, Jared; Li, Jiani; Perry, Jason K; Du Pont, Venice; Riola, Nicholas; Rodriguez, Lauren; Lu, Xianghan; Kurhade, Chaitanya; Xie, Xuping; Camus, Gregory; Manhas, Savrina; Martin, Ross; Shi, Pei-Yong; Cihlar, Tomas; Porter, Danielle P; Mo, Hongmei; Maiorova, Evguenia; Bilello, John P.
Afiliación
  • Pitts J; Gilead Sciences, Inc., Foster City, California, USA.
  • Li J; Gilead Sciences, Inc., Foster City, California, USA.
  • Perry JK; Gilead Sciences, Inc., Foster City, California, USA.
  • Du Pont V; Gilead Sciences, Inc., Foster City, California, USA.
  • Riola N; Gilead Sciences, Inc., Foster City, California, USA.
  • Rodriguez L; Gilead Sciences, Inc., Foster City, California, USA.
  • Lu X; Gilead Sciences, Inc., Foster City, California, USA.
  • Kurhade C; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Camus G; Gilead Sciences, Inc., Foster City, California, USA.
  • Manhas S; Gilead Sciences, Inc., Foster City, California, USA.
  • Martin R; Gilead Sciences, Inc., Foster City, California, USA.
  • Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
  • Cihlar T; Gilead Sciences, Inc., Foster City, California, USA.
  • Porter DP; Gilead Sciences, Inc., Foster City, California, USA.
  • Mo H; Gilead Sciences, Inc., Foster City, California, USA.
  • Maiorova E; Gilead Sciences, Inc., Foster City, California, USA.
  • Bilello JP; Gilead Sciences, Inc., Foster City, California, USA.
Antimicrob Agents Chemother ; 66(6): e0022222, 2022 06 21.
Article en En | MEDLINE | ID: mdl-35532238

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos